Citadel Advisors’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Citadel Advisors’s Portfolio TFFP Stock Details TFFP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-168	Closed	-$2.88K	–	15424
2023 Q1	$2.88K	Sell	168 -596	-78%	-$12.9K	﹤0.01%	14101
2022 Q4	$20.1K	Sell	764 -1,024	-57%	-$48.6K	﹤0.01%	13142
2022 Q3	$181K	Buy	1,788 +640	+56%	+$86.6K	﹤0.01%	10506
2022 Q2	$162K	Sell	1,148 -732	-39%	-$102K	﹤0.01%	10907
2022 Q1	$297K	Sell	1,880 -2,048	-52%	-$331K	﹤0.01%	10626
2021 Q4	$871K	Buy	3,928 +1,060	+37%	+$205K	﹤0.01%	8289
2021 Q3	$554K	Buy	2,868 +1,008	+54%	+$214K	﹤0.01%	9616
2021 Q2	$447K	Sell	1,860 -148	-7%	-$40.6K	﹤0.01%	10306
2021 Q1	$681K	Buy	2,008 +504	+34%	+$205K	﹤0.01%	9006
2020 Q4	$538K	Hold	1,504	–	–	﹤0.01%	8005
2020 Q3	$694K	Buy	+1,504	New	+$424K	﹤0.01%	6707

Other funds holding TFFP

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Citadel Advisors's TFFP Position: Q4 2024 in Review

Citadel Advisors sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q4 2024, closing a stake of 13,579 shares — an estimated $27.3K sold.

Citadel Advisors first reported a position in TFFP in Q3 2020 and held it in 12 quarters. The position peaked at $1.32M in Q3 2020. 4 funds tracked by Wall St. Rank hold TFFP as of Q4 2024.

Citadel Advisors reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Citadel Advisors sold 13,579 TFF Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $27.3K.
Citadel Advisors first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 12 quarters.
Citadel Advisors's TFF Pharmaceuticals, Inc. Common Stock position peaked at $1.32M in Q3 2020.
4 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.